“ I am long on SNG now. Not much more to research as it’s wait and see so I rarely look in there now same as a few others.”
Exactly the position of most on here. So you’ll understand your posting is met with rolled eyes.
And the flowflex story… wow. That has been around and discussed on this board for months. Literally months. Weekend news digested well?? The news was old. Already part of the SP fall.
Nothing new. No more research. Like you’re doing on SNG - wait of walk.
Still find it very odd that he gets so excited but has not single a penny invested in the company. Can’t afford to lose traction on his blue chips apparently… very odd.
That said, there’s others that live this stock, yet aren’t invested. At least he’s positive.
If the house purchase is to be believed, he needed cash at that particular time. At £3+ he’ll have all of the cash he’ll ever need. Throwing his current cash flow back into the business at this stage makes little sense as a personal strategy.
I think the market would welcome it. However, AS is heavily incentivised at £3+ I seem to remember? A £50-100k investment with his own money between now and this might not make much sense, other than serve the purpose you state.
Somebody asking for info on the Biosynex test. I’ve looked into this before, and low and behold, yet another repurposed NP test. The more you look, the vast majority are validating their tests using NP Swabs, then leading with Nasal swab use.
Also, the nasal swab IFU states 2-4cm insertion, or obstruction, I.e MNT.
Our test has no competition in performance, when used as intended. 1cm vs 4cm. Huge margin for error, while performing better in real world setting. Some would say that’s non-invasive.